Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Amyloid-Beta Radiotracer [F]BF-227 Does Not Bind to Cytoplasmic Glial Inclusions of Postmortem Multiple System Atrophy Brain Tissue.

Authors:
Mathieu Verdurand Elise Levigoureux Sophie Lancelot Waël Zeinyeh Thierry Billard Isabelle Quadrio Armand Perret-Liaudet Luc Zimmer Fabien Chauveau

Contrast Media Mol Imaging 2018 6;2018:9165458. Epub 2018 Feb 6.

Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.

The accumulation of aggregated alpha-synuclein (-syn) in multiple brain regions is a neuropathological hallmark of synucleinopathies. Multiple system atrophy (MSA) is a synucleinopathy characterized by the predominant cerebral accumulation of aggregated -syn as cytoplasmic glial inclusions (CGI). A premortem diagnosis tool would improve early diagnosis and help monitoring disease progression and therapeutic efficacy. One Positron Emission Tomography (PET) study suggested [C]BF-227 as a promising radiotracer for monitoring intracellular -syn deposition in MSA patients. We sought to confirm the binding of this radiotracer to -syn using state-of-the-art autoradiography. Medulla sections were obtained from 9 MSA patients and 9 controls (London Neurodegenerative Diseases Brain Bank). [F]BF-227, chemically identical to [C]BF-227, was used at nanomolar concentrations to perform autoradiography assays. Autoradiograms were superimposed on fluorescent staining from the conformational anti--syn antibody 5G4 and quantified after immunofluorescence-driven definition of regions of interest. Autoradiography showed no specific signals in MSA patients in comparison to controls despite widespread pathology detected by immunofluorescence. Autoradiography does not support a significant binding of [F]BF-227 to CGI at concentrations typically achieved in PET experiments.

Download full-text PDF

 Source
http://dx.doi.org/10.1155/2018/9165458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818909PMC
July 2019

Publication Analysis

Top Keywords

msa patients
12
multiple system
8
system atrophy
8
accumulation aggregated
8
cytoplasmic glial
8
glial inclusions
8
autoradiography medulla
4
chemically identical
4
[f]bf-227 chemically
4
identical [c]bf-227
4
[c]bf-227 nanomolar
4
autoradiography
4
state-of-the-art autoradiography
4
medulla sections
4
sections msa
4
bank [f]bf-227
4
neurodegenerative diseases
4
diseases brain
4
london neurodegenerative
4
-syn state-of-the-art
4

Altmetric Statistics


Show full details
1 Total Shares
1 News Outlets
1 Citations

Similar Publications

Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.

Authors:
Shunsuke Koga Maiko Ono Naruhiko Sahara Makoto Higuchi Dennis W Dickson

Mov Disord 2017 06 25;32(6):884-892. Epub 2017 Apr 25.

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.

Background: The tau PET ligand 2-((1E,3E)-4-(6-([ C]methylamino)pyridin-3-yl)buta-1,3-dienyl)benzo[d]thiazol-6-ol ([ C]PBB3) binds to a wide range of tau pathology; however, binding property of PBB3 to non-tau inclusions remains unknown. To clarify whether [ C]PBB3 binds to α-synuclein pathology, reactivity of PBB3 was assessed by in vitro fluorescence and autoradiographic labeling of brain sections from α-synucleinopathies patients.

Method: Of 10 pure Lewy body disease and 120 multiple system atrophy (MSA) cases in the Mayo Clinic brain bank, we selected 3 Lewy body disease and 4 MSA cases with a range of α-synuclein severity based on the quantitative analysis of α-synuclein burden. Read More

View Article and Full-Text PDF
June 2017

In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy.

Authors:
Akio Kikuchi Atsushi Takeda Nobuyuki Okamura Manabu Tashiro Takafumi Hasegawa Shozo Furumoto Michiko Kobayashi Naoto Sugeno Toru Baba Yasuo Miki Fumiaki Mori Koichi Wakabayashi Yoshihito Funaki Ren Iwata Shoki Takahashi Hiroshi Fukuda Hiroyuki Arai Yukitsuka Kudo Kazuhiko Yanai Yasuto Itoyama

Brain 2010 Jun 29;133(Pt 6):1772-8. Epub 2010 Apr 29.

Department of Neurology, Graduate School of Medicine, Tohoku University, Sendai, 980-8574 Japan.

The histopathological hallmark of multiple system atrophy is the appearance of intracellular inclusion bodies, named glial cytoplasmic inclusions, which are mainly composed of alpha-synuclein fibrils. In vivo visualization of alpha-synuclein deposition should be used for the diagnosis and assessment of therapy and severity of pathological progression in multiple system atrophy. Because 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy] benzoxazole could stain alpha-synuclein-containing glial cytoplasmic inclusions in post-mortem brains, we compared the carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy] benzoxazole positron emission tomography findings of eight multiple system atrophy cases to those of age-matched normal controls. Read More

View Article and Full-Text PDF
June 2010

In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging.

Authors:
Mathieu Verdurand Elise Levigoureux Wael Zeinyeh Laurent Berthier Meriem Mendjel-Herda Florence Cadarossanesaib Caroline Bouillot Thibault Iecker Raphaël Terreux Sophie Lancelot Fabien Chauveau Thierry Billard Luc Zimmer

Mol Pharm 2018 08 25;15(8):3153-3166. Epub 2018 Jul 25.

Université de Lyon, Université Claude Bernard Lyon 1, Lyon Neuroscience Research Center, CNRS UMR5292, INSERM U1028 , Lyon 69361 , France.

Accumulation of α-synuclein (α-syn) is a neuropathological hallmark of synucleinopathies. To date, no selective α-syn positron emission tomography (PET) radiotracer has been identified. Our objective was to develop the first original, selective, and specific α-syn PET radiotracer. Read More

View Article and Full-Text PDF
August 2018

The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.

Authors:
Marcos Herrera-Vaquero Danielle Bouquio Martin Kallab Karl Biggs Gayatri Nair Jessica Ochoa Antonio Heras-Garvin Christian Heid Inesa Hadrovic Werner Poewe Gregor K Wenning Frank-Gerrit Klärner Thomas Schrader Gal Bitan Nadia Stefanova

Biochim Biophys Acta Mol Basis Dis 2019 11 16;1865(11):165513. Epub 2019 Jul 16.

Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Austria. Electronic address:

Multiple system atrophy (MSA) is a fatal, adult-onset neurodegenerative disorder that has no cure and very limited treatment options. MSA is characterized by deposition of fibrillar α-synuclein (α-syn) in glial cytoplasmic inclusions in oligodendrocytes. Similar to other synucleinopathies, α-syn self-assembly is thought to be a key pathologic event and a prominent target for disease modification in MSA. Read More

View Article and Full-Text PDF
November 2019